China Life Insurance Company Limited (2628.HK) Bundle
From its roots as the People's Insurance Company of China in 1949 to its 2003 rebranding and Hong Kong listing as 2628.HK, China Life Insurance Company Limited has grown into China's largest life insurer with a market capitalization near HK$1.28 trillion (Dec 19, 2025) and a majority owner-China Life Insurance (Group) Company-holding 68.37% of shares; the firm, ranked 94th on the 2015 Fortune Global 500, operates across Life, Health, Accident and Other segments, processes over 20 million claims annually, runs the industry's largest sales force while accelerating digital upgrades, and posts record gross written premiums of RMB 608.2 billion (+5.1% YoY) alongside a surge in investment income (gross investment income up 152% YoY) and robust solvency metrics (core solvency ratio 154.58%, comprehensive 211.64%), all under a mission to build a world-class insurer with Chinese characteristics, deepen reforms and sustain profitability through underwriting and investment income-details on ownership stakes, recent transactions (including the 2025 AMP framework renewal and the Dec 30, 2025 EGM), the 2022 ADS delisting, continued operations in Russia, and analysts' HK$31.00 price target are explored in the full article
China Life Insurance Company Limited (2628.HK): Intro
China Life Insurance Company Limited (2628.HK) is one of China's largest state-backed life insurers, with roots going back to 1949 when it was established as the People's Insurance Company of China (PICC). The firm restructured and rebranded in 2003 to focus on life insurance, listed H-shares on the Hong Kong Stock Exchange (2628.HK) the same year, and has since operated a broad suite of life, health and pension insurance, and asset-management businesses. Notable corporate milestones include a Fortune Global 500 ranking (94th in 2015) and the delisting of its ADS program effective September 1, 2022. As of 2025 the company maintains operations in Russia.- Founded: 1949 (as PICC)
- Restructured/rebranded: 2003 (China Life Insurance Company Limited)
- H-share listing: 2003 (HKEx: 2628.HK)
- ADS delisted: Sept 1, 2022
- Fortune Global 500: #94 (2015)
- Continues operations in Russia as of 2025
- 1949-2002: Originated as PICC, state-owned insurer serving the newly established PRC.
- 2003: Major restructuring split PICC businesses; China Life focused on life and pensions and completed an H-share IPO in Hong Kong.
- Post-2003 to present: Expansions into bancassurance, agent networks, health insurance and asset management; selective international footprint.
- Ownership: majority-owned by the state through China Life Insurance (Group) Company (the parent/group holding company). As reported in recent annual disclosures, the parent/group and state-related entities remain the largest shareholders, collectively controlling a majority stake (majority-held via state-controlled group companies).
- Core business lines:
- Individual life insurance (traditional and participating policies)
- Health and critical-illness insurance
- Group and pension products (enterprise annuities, occupational pensions)
- Investment and asset management (managing insurer's general account and third-party AUM)
- Distribution channels:
- Agency force (large field sales force)
- Bancassurance partnerships with major banks
- Direct and digital channels
- Revenue generation:
- Premium income (first-year premiums and renewal premiums)
- Net investment income (interest, dividends, realized/unrealized gains on bond and equity portfolios)
- Fee income from asset management and wealth-management services
- Policyholder account management and financial products distributed via bancassurance
| Metric | Value | Reference Year |
|---|---|---|
| Total assets | RMB 5.6 trillion | FY2023 (group consolidated) |
| Assets under management (AUM) | RMB 5.2 trillion | FY2023 |
| Total revenue / operating revenue | RMB 450-480 billion | FY2023 (approx.) |
| Net profit (attributable) | RMB ~40 billion | FY2023 |
| Embedded value / EV (indicative) | RMB several hundred billion | Latest disclosure period |
| Market capitalization (HKD) | HKD ~300-450 billion | Range indicative as of 2024-2025 trading |
- Underwriting margin: pricing life and health risks; profit emerges where premiums and investment returns exceed claims, lapses and expenses.
- Investment spread: insurers invest collected premiums in fixed income, equities and alternative assets; net investment yield minus policy guarantees and liabilities creates a key earnings stream.
- Fee income: asset management fees, fund-management and bancassurance distribution fees contribute recurring fee revenue.
- Scale and distribution: a large agent network and bancassurance scale lower acquisition costs per policy and increase persistency, improving lifetime value of policies.
- Liability management: product design (e.g., participating vs. traditional policies) and hedging direct exposure to interest-rate and longevity risk help protect margins.
- Agent force and bancassurance partners form the backbone of new-business acquisition; digital channels growing to capture younger demographics.
- Product mix has shifted over time toward protection, pensions and fee-based wealth products to diversify revenue and reduce sensitivity to interest-rate changes.
- State ownership subject to PRC regulatory framework and supervision; capital adequacy and solvency maintained per China's insurance regulatory rules.
- Geopolitical exposure: maintains selective overseas operations (including Russia as of 2025) and has adjusted listings/market access (e.g., ADS delisting in 2022 citing low volume and administrative cost).
- Strengthening bancassurance and agency productivity through digital tools and training.
- Expanding pension and health businesses to capture aging-population demand in China.
- Prudential investment management: diversifying investments across fixed income, equities and alternatives while managing guarantee liabilities.
- Group governance: coordination between listed China Life Insurance Company Limited and the state-owned parent/group for capital allocation and strategic planning.
China Life Insurance Company Limited (2628.HK): History
China Life Insurance Company Limited (2628.HK) traces its roots to the state-backed life insurance system established in the PRC; it was listed in Hong Kong to broaden capital access and international visibility while remaining majority-owned by its parent group. Over decades the company expanded from traditional life insurance into pensions, health insurance, asset management and bancassurance, becoming one of China's largest insurers by premiums and assets under management.- Majority owner: China Life Insurance (Group) Company - 68.37%.
- Significant minority holders: China Securities Finance Corporation Limited - 2.03%; Central Huijin Investment Ltd. - 0.42%.
- Public float traded on the Hong Kong Stock Exchange; constituent of Hang Seng Index and CSI 300.
| Metric | Value |
|---|---|
| Market capitalization (HK$) | ≈ HK$1.28 trillion (as of 19 Dec 2025) |
| Parent stake | 68.37% |
| China Securities Finance | 2.03% |
| Central Huijin | 0.42% |
| Index membership | Hang Seng Index; CSI 300 |
| Latest material agreements | Framework Agreement with AMP renewed through 31 Dec 2025 |
| Governance event | Extraordinary general meeting scheduled 30 Dec 2025 (investment agreements & connected transactions) |
- Connected transactions: framework renewed to 31 Dec 2025 with AMP, enabling continued related-party arrangements under specified terms.
- EGM (30 Dec 2025): set to review resolutions tied to investment agreements and connected transactions arising from the renewed framework.
China Life Insurance Company Limited (2628.HK): Ownership Structure
China Life Insurance Company Limited (2628.HK) positions itself as a state-controlled market leader with a mission to build a world-class life insurer with Chinese characteristics. The company emphasizes innovation-driven growth, efficient coordination, modern governance, and alignment with national financial-strengthening goals. It explicitly targets enhanced investor returns, high solvency adequacy, value creation, profitability improvement, and sustainable development while deepening reforms to adapt to stricter regulatory trends. The company's stated focus areas include:- Innovation-driven product and service development to meet evolving customer needs.
- Efficient coordination across life insurance, annuities, asset management and pension services.
- Maintaining robust solvency and risk-management frameworks to safeguard policyholders and investors.
- Supporting national financial-strength initiatives and contributing to China's economic strategy.
- Majority control: State-owned parent - China Life Insurance (Group) Company Ltd - serves as the controlling shareholder, reflecting government-aligned strategic direction.
- Public float: H-share holders on the Hong Kong Stock Exchange and A-share holders on the Shanghai/Shenzhen markets (through parent and affiliates) provide market discipline and capital access.
- Institutional investors: Domestic and international asset managers, sovereign wealth funds and insurance-linked investors hold significant free-float positions.
| Metric | Value | Notes / Source Year |
|---|---|---|
| Total assets | RMB 4.2 trillion | FY 2023 (company filings) |
| Shareholders' equity | RMB 235 billion | FY 2023 |
| Net profit (attributable) | RMB 27.5 billion | FY 2023 |
| Embedded value / EV | RMB 520 billion | Latest actuarial disclosure |
| Solvency margin ratio (core / total) | Core solvency ~180% / Overall solvency ~230% | Regulatory disclosure, 2023 |
| Controlling shareholder stake | >50% (China Life Insurance (Group) Company Ltd) | Public filings, 2024 |
| Free float (H-share market) | ~30-40% | HKEX register, 2024 |
- State-aligned ownership supports long-horizon policyholder-focused strategy and access to capital during reforms.
- Majority control allows integrated coordination with the group's asset management, pension and health service arms for product distribution and risk diversification.
- Public listing and significant institutional free float impose market discipline, pushing for transparency, profitability improvement and stronger returns on equity.
- Regulatory focus on solvency and risk means ownership must sustain capital injections, reinsurance strategies, and asset-liability management to meet tightening requirements.
China Life Insurance Company Limited (2628.HK): Mission and Values
China Life Insurance Company Limited (2628.HK) is one of China's largest life insurers, with a mission centered on long-term protection, financial security, and service quality for individuals, families and corporate clients. The company emphasizes integrity, customer-first service, professional excellence and innovation as core values that guide product design, distribution and claims service. How It Works China Life operates through four primary business segments that cover the spectrum of life and personal risk protection:- Life Insurance Business - traditional life, participating life and savings-oriented life products for individual and group customers.
- Health Insurance Business - critical illness, medical reimbursement and supplementary health products increasingly focused on higher-frequency claims and managed care.
- Accident Insurance Business - personal accident and workplace accident cover for individuals and corporate schemes.
- Other Businesses - pension/annuities, asset management and fee-based bancassurance and agency services.
- Offers life, annuity, health and accident insurance for individuals and groups across urban and rural markets.
- Extensive agency and bancassurance channels: historically the largest individual agent force in China, focused on transforming into a specialized, professional and integrated individual agent team to improve persistency and cross-sell.
- Growing digital and bancassurance channels serving younger and urban customers.
- Processes over 20 million claims annually, underpinning a leading position in claims settlement efficiency and customer service experience.
- Brand program "China Life Good Services" emphasizes convenience, quality and care across claims, policy servicing and digital touchpoints.
- Deploys big data, AI and automated underwriting to improve risk selection, pricing and claims triage.
- Uses digital CRM, mobile apps and tele-underwriting to shorten sales cycles, increase straight-through processing and improve persistency metrics.
| Revenue/Balance Sheet Item | Illustrative Recent Value | Notes |
|---|---|---|
| Total premium income (annual) | ~RMB 700-800 billion | Aggregate individual and group premiums from life, health and accident lines |
| Investment income (annual) | ~RMB 200-350 billion | Interest, dividends, and realized/unrealized gains on bond and equities portfolio |
| Total assets | Over RMB 4 trillion | Insurance funds and invested assets managed for policy liabilities |
| Net profit / attributable to shareholders (annual) | RMB tens of billions | Driven by underwriting margin plus investment returns |
| Agent force size | Over 1 million individual agents (industry-leading) | Ongoing transformation to a professional, integrated individual agent team |
| Claims processed per year | Over 20 million | Reflects high-frequency health and life claims volume |
- Premiums collected - recurring and single-premium business funds future claim obligations and provides a stable inflow of investable float.
- Investment spread - invest premiums in fixed income, equities and alternatives; earn investment returns in excess of policy liability yields to generate investment income.
- Underwriting profit - pricing, risk selection and expense control determine loss ratios and underwriting margin for life, health and accident products.
- Fee income - asset management, pension management and bancassurance/service fees supplement underwriting and investment returns.
- Reinsurance and risk-transfer - cedes portions of risk and uses reinsurance to manage capital volatility and mortality/morbidity exposure.
- Improve persistency and reduce lapses via product redesign and agent professionalization to protect long-term margins.
- Enhance digital straight-through processing to lower acquisition and servicing costs and speed claims settlement.
- Optimize investment portfolio duration and credit exposure to match long-dated life liabilities and stabilize returns.
- Strengthen health and accident product offerings to capture higher-frequency premium flows and build lifetime customer relationships.
- Premium growth (y/y) across individual and group lines
- Net investment yield and realized/unrealized gains
- Combined loss ratio / claims ratio for health and accident; mortality experience for life business
- Persistency rates (13th-month, 25th-month) and agent productivity
- Solvency margin and regulatory capital adequacy
China Life Insurance Company Limited (2628.HK): How It Works
China Life Insurance Company Limited (2628.HK) operates as one of China's largest life insurers, combining insurance underwriting, asset management and distribution to generate revenue and shareholder value. Its core business model centers on risk pooling, premium collection, liability management and long-duration investment of policyholder funds.- Primary revenue sources:
- Underwriting: life, health and accident insurance premiums from individual and group policyholders.
- Investment income: returns on invested premiums across fixed income, equities, real estate, and alternative assets.
- Fee and commission income: asset management fees, bancassurance and agency commissions.
- Other income: reinsurance recoveries, service fees and ancillary financial services.
- Distribution channels:
- Bancassurance partnerships (major bank networks).
- Retail agency force and financial advisers.
- Direct and digital sales platforms.
- Risk and capital management:
- Actuarial reserving and liability matching to manage long-term guarantees.
- Reinsurance to transfer peak risks and stabilize results.
- Robust solvency governance to preserve regulatory capital adequacy.
| Metric | Latest Reported Figure | YoY Change / Note |
|---|---|---|
| Gross written premiums | RMB 608.2 billion | +5.1% YoY (record high) |
| Gross investment income | - | +152% YoY (reported strong growth) |
| Core solvency ratio | 154.58% | Indicates strong regulatory capital coverage |
| Comprehensive solvency ratio | 211.64% | Reflects overall capital adequacy |
- Premiums collected provide the primary float: underwriting margins depend on mortality/morbidity experience, product mix (protection vs. savings), and expense control.
- Investing the float generates investment yield; a reported 152% YoY increase in gross investment income materially lifted operating profitability in the reporting period.
- Asset-liability management (duration matching, credit selection) reduces the risk of forced asset realization and supports stable long-term returns.
- Improving product mix toward higher-margin protection and fee-based savings products supports value creation and sustainable earnings.
- Focus on value creation: prioritize profitable product lines and customer retention.
- Profitability improvement: cost discipline, channel optimization and higher-margin distribution.
- Sustainable development: prudent investment strategy, ESG integration and capital resilience (evidenced by 154.58% core solvency and 211.64% comprehensive solvency).
China Life Insurance Company Limited (2628.HK): How It Makes Money
China Life is China's largest life insurer by market share and generates revenue and profit through a mix of underwriting, investment returns, and fee-based businesses. It leverages scale, distribution (including bancassurance), and asset management to convert premiums into long-term shareholder value while navigating regulatory and market shifts.- Core revenue streams: net written premiums from life, health and annuity products; recurring policy fees and service charges; and commissions from distribution partners.
- Investment income: returns on a large investment portfolio (fixed income, equities, alternatives) that supports guaranteed liabilities and surplus generation.
- Asset management and wealth management fees: third-party and proprietary fund management for retail and institutional clients.
- Bancassurance and agency channels: broad distribution network driving new business and cross‑selling opportunities.
| Metric | Value / Note |
|---|---|
| Market Position | China's largest life insurer by market share (2025) |
| Market Capitalization | ≈ HK$1.28 trillion (2025) |
| Analyst Price Target | HK$31.00 |
| Projected Net Profit Growth | 50%-70% increase for first three quarters of 2025 vs same period in 2024 |
| Business Mix | Life & health premiums, investment returns, fee income, asset management |
| Strategic Focus | High-quality development, governance reform, regulatory adaptation |
- Profit drivers include product mix optimization toward protection and savings with higher margins, improved expense ratios via digitalization, and enhanced investment returns from diversified portfolios.
- Risks include interest-rate and credit market movements, regulatory capital requirements, and competitive pressure from private and tech-enabled insurers.

China Life Insurance Company Limited (2628.HK) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.